Nadia Bambace is an Oncology physician affiliated with Baptist Hospital of Miami. OpenAlex indexes 76 publications with 1,568 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8900 N Kendall Dr
Miami, FL 331762118
Telephone
786-596-2000Provider last certified this registry record 23 Aug 2022.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- GENZYME CORPORATIONProgram year20252 payments
- Gamida Cell Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
32.2%Proton pump inhibitor17.4%Pantoprazole Sodium100%Part D<11 patientsBile Acid14.9%Ursodiol100%Part D<11 patientsCancer & immunology
20.7%Kinase inhibitor10.7%Iclusig100%Part D<11 patientsBCL-2 Inhibitor9.9%Venclexta100%Part D<11 patientsAnti-infectives
19.8%Azole Antifungal9.9%Posaconazole100%Part D<11 patientsCytomegalovirus DNA Terminase Complex Inhibitor9.9%Prevymis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
Biology of Blood and Marrow Transplantation
2025 - A Pilot Study of UM171-Expanded Cord Blood Grafts for Tandem Auto/Allogeneic Hematopoietic Cell Transplant in High and Ultra-High-Risk Myeloma Patients
Biology of Blood and Marrow Transplantation
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Lyle Feinstein, MD
Baptist Hospital of Miami
Horacio Asbun, MD
Baptist Hospital of Miami
Ricardo Cury, MD
Baptist Hospital of Miami
Atulya Khosla, MD
Baptist Hospital of Miami
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”